AVELOX

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Mexico, New Zealand, Nigeria, Romania, Singapore, Turkey, UK.

Active ingredients

The drug AVELOX contains one active pharmaceutical ingredient (API):

1	Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE
	Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.
	Read more about Moxifloxacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AVELOX Solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
AVELOX Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA14	Moxifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29379-09-10, 29685-03-11
EE	Ravimiamet	1154551, 1154562, 1154573, 1154607, 1154618, 1154629, 1154630, 1154641, 1154652, 1154663, 1154674, 1154685
FI	Lääkealan turvallisuus- ja kehittämiskeskus	385813, 492411
GB	Medicines & Healthcare Products Regulatory Agency	104964, 167520, 167521, 175337, 185459, 43608
HK	Department of Health Drug Office	46950, 50810
IE	Health Products Regulatory Authority	53501, 53507, 53525
JP	医薬品医療機器総合機構	6241016F1028
LT	Valstybinė vaistų kontrolės tarnyba	1016709, 1016710, 1016711, 1016712, 1018689, 1018690, 1018691, 1055157, 1055158, 1055159, 1055160, 1055161, 1055162, 1085581, 1085935
MT	Medicines Authority	MA639/01602
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	174M2001, 590M98
NG	Registered Drug Product Database	A4-3297
Switch country to Nigeria in order to find specific presentations of AVELOX
NZ	Medicines and Medical Devices Safety Authority	10185, 9057
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63876001, W63876002, W63876003, W63876004, W63876007, W63876008, W63876009, W63876010, W63876011, W63876012, W63876015, W63876016, W63876017, W63876018, W63876020, W63876021, W63876022, W63876024, W63876025, W63876026, W63876027, W63876028, W63876029, W63876030, W63876031, W63877001, W63877002, W63877003, W63877004
SG	Health Sciences Authority	11351P, 11971P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546090129, 8699546090372, 8699546090433